BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gao A, Pan X, Yang X, Lin Z. Predictive factors in the treatment of oral squamous cell carcinoma using PD-1/PD-L1 inhibitors. Invest New Drugs 2021;39:1132-8. [PMID: 33594603 DOI: 10.1007/s10637-021-01082-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Pan X, Gao A, Hu Y, Hu Z, Xie C, Lin Z. Gadolinium-containing semiconducting polymer nanoparticles for magnetic resonance/fluorescence dual-modal imaging and photothermal therapy of oral squamous cell carcinoma. Nano Res . [DOI: 10.1007/s12274-022-4947-5] [Reference Citation Analysis]
2 Yang Z, Liao B, Yang S, Su T, Zhang J, Wang W. Predictive Role of NEK6 in Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma. Front Endocrinol 2022;13:943686. [DOI: 10.3389/fendo.2022.943686] [Reference Citation Analysis]
3 Weber M, Lutz R, Olmos M, Glajzer J, Baran C, Nobis C, Möst T, Eckstein M, Kesting M, Ries J. Beyond PD-L1—Identification of Further Potential Therapeutic Targets in Oral Cancer. Cancers 2022;14:1812. [DOI: 10.3390/cancers14071812] [Reference Citation Analysis]
4 Souza VGD, Santos DJS, Silva AG, Ribeiro RIMDA, Loyola AM, Cardoso SV, Miranda CSS, Cardoso LPV. Immunoexpression of PD-L1, CD4+ and CD8+ cell infiltrates and tumor-infiltrating lymphocytes (TILs) in the microenvironment of actinic cheilitis and lower lip squamous cell carcinoma. J Appl Oral Sci 2022;30:e20210344. [DOI: 10.1590/1678-7757-2021-0344] [Reference Citation Analysis]
5 Gao L, Chen R, Sugimoto M, Mizuta M, Kishimoto Y, Omori K. The Impact of m1A Methylation Modification Patterns on Tumor Immune Microenvironment and Prognosis in Oral Squamous Cell Carcinoma. Int J Mol Sci 2021;22:10302. [PMID: 34638642 DOI: 10.3390/ijms221910302] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]